Frankfurt Pharma Hub Prepares For Covid Vaccine Task

As a string of Covid-19 vaccines near approval, Frankfurt Airport staff are gearing up to handle the unprecedented logistical challenge of transporting millions of life-saving doses worldwide.

Frankfurt is Europe’s largest hub for transporting pharmaceutical goods, and will be key to the success of inoculating millions of people against the deadly coronavirus.

“The stress is increasing now that we’re entering the ‘hot’ phase,” Karin Krestan, Lufthansa Cargo’s director of operations, told AFP during a tour of the temperature-controlled “Cargo Cool Center” terminal.

Krestan, who uses her skills as a former nurse, is sure her team is ready for the task.

The Frankfurt airport has 12,000 square metres (129,000 square feet) of temperature-controlled warehouses, essential for storing medicines The Frankfurt airport has 12,000 square metres (129,000 square feet) of temperature-controlled warehouses, essential for storing medicines Photo: AFP / Thomas Lohnes

“The processes have been established, we’re very confident and we feel well prepared,” she said.

In fact, Max Philipp Conrady, head of freight infrastructure at Fraport, told AFP:

Read More

Vaccine Maker AstraZeneca’s Computer Systems Targeted by Hackers

As the race to develop the COVID-19 vaccine continues, it appears that suspected North Korean hackers attempted to access AstraZeneca’s systems in the last weeks.

Reuters reports that the hackers pretended to be job recruiters and used LinkedIn and WhatsApp to contact AstraZeneca employees with false job offers. Sources told the news outlet that the hackers then sent documents that they claimed were job descriptions but instead were written with harmful code to gain entry into the victims’ computers.

The hackers targeted a “broad set of people” like COVID-19 researchers, but it doesn’t appear that their break-in attempts were successful. AstraZeneca, Pfizer, and Moderna have become the top three COVID-19 vaccine developers.

Sources told Reuters that the hackers’ tools and techniques seemed to be that of a current hacking campaign that has been assigned to North Korea. Cyberattacks targeting drugmakers, health bodies, and vaccine scientists have escalated since the outset

Read More

Logmore Launches First Logistics Monitor Designed for COVID-19 Vaccine Delivery

HELSINKI–(BUSINESS WIRE)–November 25, 2020–

Supply chain analytics solution provider Logmore has announced the launch of its latest product. Logmore Dry Ice, a high-spec version of Logmore’s original data recorder, has been adapted for cold and sub-zero conditions. The solution is designed for sensitive shipments, such as the COVID-19 vaccine the moment it becomes available.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201125005841/en/

COVID 19 Logistics Monitor by Logmore (Photo: Logmore)

COVID 19 Logistics Monitor by Logmore (Photo: Logmore)

Since its founding in 2017, Logmore has disrupted logistics monitoring with its use of loggers that sync with the cloud using dynamic QR codes, allowing anyone with a smartphone to update secure systems with the latest conditions and locations of shipments.

Logmore Dry Ice redefines monitoring of cold chain shipments from standard fridge temperatures (2-8°C) all the way down to deep freeze levels of -100°C. This makes it ideal for transporting the COVID-19 vaccines, which require deep

Read More

Facebook plans to woo Biden with vaccine, climate change features: FT

  • Facebook is building a strategy to help get on President-elect Joe Biden’s good side, company sources told the Financial Times.
  • Facebook is reportedly planning to crack down harder on COVID-19 misinformation, and is considering adding an information banner to its site encouraging users to get vaccinated.
  • Facebook is also reportedly looking at ways to encourage users to engage with content about the Paris Climate Agreement, which Biden has pledged to rejoin. The US left the agreement in November.
  • Facebook plans to make Nick Clegg its main point of contact with Washington, the FT reported. Clegg was deputy prime minister in Britain during Biden’s term as vice-president.
  • Visit Business Insider’s homepage for more stories.

Facebook is gearing up to woo President-elect Joe Biden by promoting vaccine and climate change information, according to a report from the Financial Times.

Citing anonymous company “insiders,” the FT reports Facebook is planning to crack down

Read More

Sorrento Therapeutics Plans to Cut Development of Its Coronavirus Vaccine if the Leaders’ Vaccines Work

Sorrento Therapeutics (NASDAQ:SRNE) is considerably behind Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX)Moderna (NASDAQ:MRNA), and the rest of the leaders in the race to develop a coronavirus vaccine. While multiple vaccines have completed phase 3 clinical trials or will in the coming months, Sorrento’s lead vaccine, T-VIVA-19, hasn’t even entered clinical trials yet.

In this video from Motley Fool Live recorded on Nov. 12, Henry Ji, chairman, president, and CEO of Sorrento, talks about the potential advantages of the biotech’s vaccine. But given how far behind Sorrento is, he admits the company is watching the leaders and might stop development if it’s clear there won’t be room for latecomers.

Brian Orelli: You do have a vaccine that you’re working on called T-VIVA-19. How does that work, and then what are the advantages of that over the current late-stage vaccines that are being tested right now?

Henry Ji:

Read More

North Korean, Russian hackers target COVID-19 vaccine makers

  • North Korean and Russian state-backed hacking groups have tried to target COVID-19 vaccine-makers, Microsoft said in a blog post on Friday.
  • One of the North Korean groups, known as Cerium, tried to gain access to systems by sending “spear-phishing” emails posing as WHO officials.
  • A second North Korean group, pretending to be recruiters, sent emails containing phoney job descriptions.
  •  
  • Visit Business Insider’s homepage for more stories.

State-backed hackers are trying audacious tactics to break into the systems of COVID-19 vaccine-makers.

In a blog post Friday, Microsoft detailed several attempted cyberattacks it had detected in recent months that targeted companies working on COVID-19 vaccines and treatments. Microsoft said three state-hacking groups, one Russian and two from North Korea, conducted the attacks.

Although it did not name the targets, Microsoft said they included seven “prominent” companies involved in researching COVID-19 vaccine and treatment development across the US, Canada, France, India, and South

Read More

Why Disney Could Be The Biggest Vaccine Winner

News that Pfizer and BioNTech had discovered a coronavirus vaccine that was more than 90% effective sent shockwaves through the market last week. News over the weekend that Moderna also had a highly effective vaccine nearing approval for distribution added more power to that shockwave. “Recovery stocks,” including those in consumer discretionary, energy, and banking sectors soared, while tech stocks, especially the big coronavirus winners known as “stay-at-home” stocks, fell on the news.

The announcement signaled a fundamental shift in the market psychology that has defined the pandemic era, as it now seems clear that the pandemic will have a definitive end and one that could come as soon as April. Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, estimated that the vaccine could be widely available to Americans by April, with healthcare workers getting access as soon as December.

Of course, with daily

Read More

Internet Heaps Praise on Dolly Parton After She Donated $1m to COVID-19 Vaccine Trial

Dolly Parton has once again demonstrated why she is so beloved around the world after donating $1 million to a COVID-19 vaccine trial that has been highly successful.

U.S. biotechnology firm Moderna announced on Monday that its vaccine was over 94 percent effective in protecting against coronavirus. It has now emerged that the country singer and philanthropist donated the sum towards the research for this trial.

The news follows the announcement of a separate vaccine from pharmaceutical firm Pfizer last week.

Parton’s donation came through her support of the Vanderbilt University Medical Center in Nashville, Tennessee. The New England Journal of Medicine has reported that she donated her own money to aid the research earlier this year. Footnotes in the journal show that funding came from the “Dolly Parton COVID-19 Research Fund.”

Dolly Parton
Singer-songwriter Dolly Parton attends the 51st Academy of Country Music Awards at MGM Grand Garden Arena on April
Read More

State-backed hackers targeted COVID-19 vaccine creators

State-sponsored campaigns to hack COVID-19 vaccine makers might be more commonplace than previously thought. According to ZDNet, Microsoft has detected hacks from three “nation-state actors” targeting seven pharmaceutical firms and researchers, including the US as well as Canada, France, India and South Korea. The software giant didn’t name the targets, but said the “majority” are involved in coronavirus vaccine development and research.

The campaigns reportedly come from Russia’s APT28, better known as Fancy Bear or Strontium, as well as North Korea’s Lazarus Group (aka Zinc) and a new Cerium outfit. Fancy Bear used brute force and “password spray” attempts to steal sign-in credentials, while Lazarus and Cerium have leaned on spear phishing efforts to impersonate recruiters and the World Health Organization.

Microsoft said that its products blocked most of the attempts, and that it was offering help in cases where the intruders were successful.

The news comes as Microsoft

Read More

Pfizer Vaccine, Disney Streaming, and Apple Chips on Cheddar

From Wall Street to Silicon Valley, these are the top stories that moved markets and had investors, business leaders, and entrepreneurs talking this week on Cheddar.

PFIZER’S VAX STUNNER

U.S. markets notched another winning week, propelled higher on Monday’s stunning news that Pfizer’s coronavirus vaccine trial is showing at least 90 percent efficacy in preventing infection. Pfizer, together with its partners at the German biotech firm BioNTech, are continuing Phase 3 trials, hoping for regulatory approval in the coming weeks. If that happens, it would be the biggest medical breakthrough in a century — a vaccine made from scratch in under a year — ready to be rolled out to millions of people via a complicated dance of shipping logistics, public-private cooperation, and, importantly, patience. Moderna, which is also at work on a vaccine using the same type of mRNA technology as Pfizer, is expected to release interim results from
Read More